7-Oxo-cholesterol potentiates pro-inflammatory signaling in human M1 and M2 macrophages

Biochemical Pharmacology

Volumn 86, Issue 1, 2013, Pages 130-137

  Buttari, Brigitta ^a   Segoni, Luca ^a   Profumo, Elisabetta ^a   D'Arcangelo, Daniela ^b   Rossi, Stefania ^a   Facchiano, Francesco ^a   Businaro, Rita ^c   Iuliano, Luigi ^c   Rigano, Rachele ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b LABORATORIO DI PATOLOGIA VASCOLARE   (Italy)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Atherosclerosis; Inflammation; Macrophages; Monocytes; Oxysterols

Indexed keywords

7 OXOCHOLESTEROL; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GELATINASE B; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 6; INTERLEUKIN 8; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MONOCYTE CHEMOTACTIC PROTEIN 1; RANTES; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN; 7-KETOCHOLESTEROL; CHOLESTEROL DERIVATIVE; CYTOKINE; VASCULOTROPIN A;

ANGIOGENESIS; ARTICLE; ATHEROGENESIS; CELL DIFFERENTIATION; CELL HYPOXIA; CELL VIABILITY; CYTOFLUOROMETRY; DISEASE COURSE; ENDOCYTOSIS; FLOW CYTOMETRY; HUMAN; HUMAN CELL; INFLAMMATION; MACROPHAGE; NORMAL HUMAN; OXIDATIVE STRESS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; BIOSYNTHESIS; CELL POLARITY; CELL SURVIVAL; CYTOLOGY; DRUG EFFECT; METABOLISM;

CELL HYPOXIA; CELL POLARITY; CELL SURVIVAL; CYTOKINES; ENDOCYTOSIS; GRANULOCYTE COLONY-STIMULATING FACTOR; HUMANS; INFLAMMATION; KETOCHOLESTEROLS; MACROPHAGES; MATRIX METALLOPROTEINASE 9; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84884320029     PISSN: 00062952     EISSN: 18732968     Source Type: Journal    
DOI: 10.1016/j.bcp.2013.04.008     Document Type: Article

References (49)

1. Libby P, Ridker PM, Hansson GK. Progress and challenges in translating the biology of atherosclerosis. Nature 2011;473:317-25.
2. Hansson GK, Hermansson A. The immune system in atherosclerosis. Nat Immunol 2011;12:204-12.
3. Gui T, Shimokado A, Sun Y, Akasaka T, Muragaki Y. Diverse roles of macrophages in atherosclerosis: from inflammatory biology to biomarker discovery. Mediators Inflamm 2012;2012:693083.
4. Tavakoli S, Asmis R. Reactive oxygen species and thiol redox signaling in the macrophage biology of atherosclerosis. Antioxid Redox Signal 2012;17: 1785-95.
5. Gerrity RG. The role of the monocyte in atherogenesis: I. Transition of bloodborne monocytes into foam cells in fatty lesions. Am J Pathol 1981;103: 181-90. (Pubitemid 11112973)
6. Gerrity RG. The role of the monocyte in atherogenesis: II. Migration of foam cells from atherosclerotic lesions. Am J Pathol 1981;103:191-200. (Pubitemid 11112974)
7. Gordon S, Martinez FO. Alternative activation of macrophages: mechanism and functions. Immunity 2010;32:593-604.
8. Helming L, Gordon S. Macrophage fusion induced by IL-4 alternative activation is a multistage process involving multiple target molecules. Eur J Immunol 2007;37:33-42. (Pubitemid 46128784)
9. Martinez FO, Helming L, Gordon S. Alternative activation of macrophages: an immunologic functional perspective. Annu Rev Immunol 2009;27:451-83.
10. Scotton CJ, Martinez FO, Smelt MJ, Sironi M, Locati M, Mantovani A, et al. Transcriptional profiling reveals complex regulation of the monocyte IL-1 beta system by IL-13. J Immunol 2005;174:834-45. (Pubitemid 40103564)
11. Mosser DM, Edwards JP. Exploring the full spectrum of macrophage activation. Nat Rev Immunol 2008;8:958-69.
12. Khallou-Laschet J, Varthaman A, Fornasa G, Compain C, Gaston A-T, Clement M, et al. Macrophage plasticity in experimental atherosclerosis. PLoS ONE 2010;5:e8852.
13. Geissmann F, Jung S, Littman DR. Blood monocytes consist of two principal subsets with distinct migratory properties. Immunity 2003;19:71-82. (Pubitemid 36859902)
14. Auffray C, Fogg D, Garfa M, Elain G, Join-Lambert O, Kayal S, et al. Monitoring of blood vessels and tissues by a population of monocytes with patrolling behavior. Science 2007;317:666-70. (Pubitemid 47229966)
15. Stout RD, Suttles J. Functional plasticity of macrophages: reversible adaptation to changing microenvironments. J Leukoc Biol 2004;76:509-13. (Pubitemid 39129080)
16. Liu G, Yang H. Modulation of macrophage activation and programming in immunity. J Cell Physiol 2013;228:502-12.
17. Parathath S, Mick SL, Feig JE, Joaquin V, Grauer L, Habiel DM, et al. Hypoxia is present in murine atherosclerotic plaques and has multiple adverse effects on macrophage lipid metabolism. Circ Res 2011;109:1141-52.
18. Gao L, Chen Q, Zhou X, Fan L. The role of hypoxia-inducible factor 1 in atherosclerosis. J Clin Pathol 2012;65:872-6.
19. Lewis JS, Lee JA, Underwood JC, Harris AL, Lewis CE. Macrophage responses to hypoxia: relevance to disease mechanisms. J Leukoc Biol 1999;66:889-900. (Pubitemid 30010512)
20. Iuliano L, Mauriello A, Sbarigia E, Spagnoli LG, Violi F. Radiolabeled native lowdensity lipoprotein injected into patients with carotid stenosis accumulates in macrophages of atherosclerotic plaque: effect of vitamin E supplementation. Circulation 2000;101:1249-54. (Pubitemid 30158611)
21. Micheletta F. Vitamin E supplementation in patients with carotid atherosclerosis: reversal of altered oxidative stress status in plasma but not in plaque. Arterioscler Thromb Vasc Biol 2004;24:136-40. (Pubitemid 38082424)
22. Iuliano L. Pathways of cholesterol oxidation via non-enzymatic mechanisms. Chem Phys Lipids 2011;164:457-68.
23. Traversari C, Russo V. Control of the immune system by oxysterols and cancer development. Curr Opin Pharmacol 2012;12:729-35.
24. Olkkonen VM. Macrophage oxysterols and their binding proteins: roles in atherosclerosis. Curr Opin Lipidol 2012;23:462-70.
25. Larsson H, Böttiger Y, Iuliano L, Diczfalusy U. In vivo interconversion of 7betahydroxycholesterol and 7-ketocholesterol, potential surrogate markers for oxidative stress. Free Radic Biol Med 2007;43:695-701. (Pubitemid 47102124)
26. Jessup W, Wilson P, Gaus K, Kritharides L. Oxidized lipoproteins and macrophages. Vascul Pharmacol 2002;38:239-48. (Pubitemid 36398269)
27. Berthier A, Lemaire-Ewing S, Prunet C, Montange T, Vejux A, Pais De Barros JP, et al. 7-Ketocholesterol-induced apoptosis. FEBS J 2005;272:3093-104.
28. Deckert V, Persegol L, Viens L, Lizard G, Athias A, Lallemant C, et al. Inhibitors of arterial relaxation among components of human oxidized low-density lipoproteins. Cholesterol derivatives oxidized in position 7 are potent inhibitors of endothelium-dependent relaxation. Circulation 1997;95:723-31. (Pubitemid 27063051)
29. Buttari B, Profumo E, Capozzi A, Facchiano F, Saso L, Sorice M, et al. Advanced glycation end products of human b2 glycoprotein I modulate the maturation and function of DCs. Blood 2011;117:6152-61.
30. D'Arcangelo D, Facchiano F, Barlucchi LM, Melillo G, Illi B, Testolin L, et al. Acidosis inhibits endothelial cell apoptosis and function and induces basic fibroblast growth factor and vascular endothelial growth factor expression. Circ Res 2000;86:312-8. (Pubitemid 30108825)
31. Steinman RM, Brodie SE, Cohn ZA. Membrane flow during pinocytosis. A stereologic analysis. J Cell Biol 1976;68:665-87.
32. Kajahn J, Franz S, Rueckert E, Forstreuter I, Hintze V, Moeller S, et al. Artificial extracellular matrices composed of collagen I and high sulfated hyaluronan modulate monocyte to macrophage differentiation under conditions of sterile inflammation. Biomatter 2012;2:226-73.
33. Chang J, Hisamatsu T, Shimamura K, Yoneno K, Adachi M, Naruse H, et al. Activated hepatic stellate cells mediate the differentiation of macrophages. Hepatol Res 2012.
34. Medbury HJ, James V, Ngo J, Hitos K, Wang Y, Harris DC, et al. Differing association of macrophage subsets with atherosclerotic plaque stability. Int Angiol 2013;32:74-84.
35. Herwig MC, Bergstrom C, Wells JR, Höller T, Grossniklaus HE. M2/M1 ratio of tumor associated macrophages and PPAR-gamma expression in uveal melanomas with class 1 and class 2 molecular profiles. Exp Eye Res 2013;107:52-8.
36. Leidi M, Gotti E, Bologna L, Miranda E, Rimoldi M, Sica A, et al. M2 macrophages phagocytose rituximab-opsonized leukemic targets more efficiently than m1 cells in vitro. J Immunol 2009;182:4415-22.
37. Pu H, Yin J, Wu Y, Zhang D, Wang Y, Zhou R, et al. The association between CD14 gene C-260T polymorphism and coronary heart disease risk: a metaanalysis. Mol Biol Rep 2013.
38. Dobrovolskaia MA, Vogel SN. Toll receptors, CD14, and macrophage activation and deactivation by LPS. Microbes Infect 2002;4:903-14. (Pubitemid 34775232)
39. Murray PJ, Wynn TA. Protective and pathogenic functions of macrophage subsets. Nat Rev Immunol 2011;11:723-37.
40. Peiser L, Gordon S. The function of scavenger receptors expressed by macrophages and their role in the regulation of inflammation. Microbes Infect 2001;3:149-59. (Pubitemid 32209332)
41. Shalhoub J, Falck-Hansen MA, Davies AH, Monaco C. Innate immunity and monocyte-macrophage activation in atherosclerosis. J Inflamm Lond 2011;8: 9.
42. Dollery CM, McEwan JR, Henney AM. Matrix metalloproteinases and cardiovascular disease. Circ Res 1995;77:863-8.
43. Pasterkamp G, Schoneveld AH, Hijnen DJ, de Kleijn DP, Teepen H, van der Wal AC, et al. Atherosclerotic arterial remodeling and the localization of macrophages and matrix metalloproteases 1, 2 and 9 in the human coronary artery. Atherosclerosis 2000;150:245-53. (Pubitemid 30336536)
44. Gargiulo S, Sottero B, Gamba P, Chiarpotto E, Poli G, Leonarduzzi G. Plaque oxysterols induce unbalanced up-regulation of matrix metalloproteinase-9 in macrophagic cells through redox-sensitive signaling pathways: implications regarding the vulnerability of atherosclerotic lesions. Free Radic Biol Med 2011;51:844-55.
45. Galkina E, Ley K. Immune and inflammatory mechanisms of atherosclerosis (*). Annu Rev Immunol 2009;27:165-97.
46. Porta C, Rimoldi M, Raes G, Brys L, Ghezzi P, Di Liberto D, et al. Tolerance and M2 (alternative) macrophage polarization are related processes orchestrated by p50 nuclear factor kappaB. Proc Natl Acad Sci 2009;106:14978-83.
47. Leonarduzzi G, Gamba P, Sottero B, Kadl A, Robbesyn F, Calogero RA, et al. Oxysterol-induced up-regulation of MCP-1 expression and synthesis in macrophage cells. Free Radic Biol Med 2005;39:1152-61. (Pubitemid 41407710)
48. Guida E, Stewart A. Influence of hypoxia and glucose deprivation on tumour necrosis factor-alpha and granulocyte-macrophage colony-stimulating factor expression in human cultured monocytes. Cell Physiol Biochem 1998;8: 75-88. (Pubitemid 28044158)
49. Suffee N, Hlawaty H, Meddahi-Pelle A, Maillard L, Louedec L, Haddad O, et al. RANTES/CCL5-induced pro-angiogenic effects depend on CCR1, CCR5 and glycosaminoglycans. Angiogenesis 2012;15:727-44.